Connection

Theodore Gourdin to Prostatic Neoplasms, Castration-Resistant

This is a "connection" page, showing publications Theodore Gourdin has written about Prostatic Neoplasms, Castration-Resistant.
  1. Recent advances in the treatment of advanced prostate cancer: maximizing existing therapies while searching for novel solutions. Curr Opin Oncol. 2022 05 01; 34(3):228-233.
    View in: PubMed
    Score: 0.753
  2. Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal. Curr Opin Oncol. 2021 05 01; 33(3):252-256.
    View in: PubMed
    Score: 0.703
  3. Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 05; 32(3):210-215.
    View in: PubMed
    Score: 0.656
  4. Recent advances in the management of metastatic prostate cancer: optimizing use of existing therapies, while searching for novel interventions. Curr Opin Oncol. 2018 05; 30(3):159-164.
    View in: PubMed
    Score: 0.571
  5. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. Prostate. 2022 09; 82(13):1264-1272.
    View in: PubMed
    Score: 0.190
  6. Optimization of therapies for men with advanced prostate cancer: a review of recent developments with a look toward the future. Curr Opin Oncol. 2019 05; 31(3):188-193.
    View in: PubMed
    Score: 0.153
  7. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer. 2019 05 01; 125(9):1459-1469.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.